The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro
Open accessAbstract
Raltegravir (MK-0518) is a potent inhibitor of human immunodeficiency virus (HIV) integrase and is clinically effective against viruses resistant to other classes of antiretroviral agents. However, it can select mutations in the HIV integrase gene. Nine heavily pretreated patients who received salvage therapy including raltegravir and who subsequently developed virological failure under raltegravir therapy were studied. For each patient, the sequences of the integrase-coding region were determined and compared to that at the beginning of the treatment. Four different mutation profiles were identified in these nine patients: E92Q, G140S Q148H, N155H, and E157Q mutations. For four patients, each harboring a different profile, the wild-type and mutated integrases were produced, purified, and assayed in vitro. All the mutations identified altered the activities of integrase protein: both 3′ processing and strand transfer activities were moderately affected in the E92Q mutant; strand transfer was markedly impaired in the N155H mutant; both activities were strongly impaired in the G140S Q148H mutant; and the E157Q mutant was almost completely inactive. The sensitivities of wild-type and mutant integrases to raltegravir were compared. The E92Q and G140S Q148H profiles were each associated with a 7- to 8-fold decrease in sensitivity, and the N155H mutant was more than 14-fold less sensitive to raltegravir. At least four genetic profiles (E92Q, G140S Q148H, N155H, and E157Q) can be associated with in vivo treatment failure and resistance to raltegravir. These mutations led to strong impairment of enzymes in vitro in the absence of raltegravir: strand transfer activity was affected, and in some cases 3′ processing was also impaired.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131
HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704
Integrase inhibitors to treat HIV/Aids
Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1660 · Cited by 688
HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer
Engelman, A., Mizuuchi, K., & Craigie, R. (1991) · Cell · doi:10.1016/0092-8674(91)90297-c · Cited by 655
Miller, M. D., Farnet, C. M., & Bushman, F. D. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5382-5390.1997 · Cited by 620
Goldgur, Y., Craigie, R., Cohen, G. H., Fujiwara, T., Yoshinaga, T., Fujishita, T., Sugimoto, H., Endo, T., Murai, H., & Davies, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13040 · Cited by 496
Johnson, M. S., McClure, M. A., Feng, D. F., Gray, J., & Doolittle, R. F. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.20.7648 · Cited by 480
Brown, P. O., Bowerman, B., Varmus, H. E., & Bishop, J. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2525 · Cited by 399
Markowitz, M., Morales-Ramirez, J. O., Nguyen, B.-Y., Kovacs, C. M., Steigbigel, R. T., Cooper, D. A., Liporace, R., Schwartz, R., Isaacs, R., Gilde, L. R., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31802b4956 · Cited by 368
Engelman, A., Bushman, F. D., & Craigie, R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05996.x · Cited by 350
Hazuda, D. J., Anthony, N. J., Gomez, R. P., Jolly, S. M., Wai, J. S., Zhuang, L., Fisher, T. E., Embrey, M., Guare, J. P., Egbertson, M. S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402357101 · Cited by 333
Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics
Sato, M., Motomura, T., Aramaki, H., Matsuda, T., Yamashita, M., Ito, Y., Kawakami, H., Matsuzaki, Y., Watanabe, W., Yamataka, K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600139 · Cited by 328
Espeseth, A. S., Felock, P., Wolfe, A., Witmer, M., Grobler, J., Anthony, N., Egbertson, M., Melamed, J. Y., Young, S., Hamill, T., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200139397 · Cited by 317
Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques
Hazuda, D. J., Young, S. D., Guare, J. P., Anthony, N. J., Gomez, R. P., Wai, J. S., Vacca, J. P., Handt, L., Motzel, S. L., Klein, H. J., et al. (2004) · Science · doi:10.1126/science.1098632 · Cited by 285
DeJesus, E., Berger, D., Markowitz, M., Cohen, C., Hawkins, T., Ruane, P., Elion, R., Farthing, C., Zhong, L., Cheng, A. K., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000233308.82860.2f · Cited by 270 · cited 1×
“Although both classes have been proven to be able to block HIV replication in cell culture (1, 15), only the second class was found to possess antiviral activity in vivo ( 5 , 16, 29, 34).”
BackgroundZhuang, L., Wai, J. S., Embrey, M. W., Fisher, T. E., Egbertson, M. S., Payne, L. S., Guare, Vacca, J. P., Hazuda, D. J., Felock, P. J., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm025553u · Cited by 270
Wu, X., Liu, H., Xiao, H., Conway, J. A., Hehl, E., Kalpana, G. V., Prasad, V., & Kappes, J. C. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2126-2135.1999 · Cited by 207
Hindmarsh, P., & Leis, J. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.4.836-843.1999 · Cited by 202
Human immunodeficiency virus integration in a cell-free system
Ellison, V, Abrams, H., Roe, T., Lifson, J., & Brown, P. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.2711-2715.1990 · Cited by 179
Characterization of the minimal DNA-binding domain of the HIV integrase protein
Puras Lutzke, R. A., Vink, C., & Plasterk, R. H. A. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.20.4125 · Cited by 179
Zn2+ Promotes the Self-Association of Human Immunodeficiency Virus Type-1 Integrase in Vitro
Lee, S. P., Xiao, J., Knutson, J. R., Lewis, M. S., & Han, M. K. (1997) · Biochemistry · doi:10.1021/bi961849o · Cited by 169
Zhu, K., Dobard, C., & Chow, S. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5045-5055.2004 · Cited by 159
Oligomeric States of the HIV-1 Integrase As Measured by Time-Resolved Fluorescence Anisotropy
Deprez, E., Tauc, P., Leh, H., Mouscadet, J. F., Auclair, C., & Brochon, J. (2000) · Biochemistry · doi:10.1021/bi000397j · Cited by 144
Self-citationLeh, H., Brodin, P. M., Bischerour, J., Deprez, E., Tauc, P., Brochon, J., Cam, É. L., Coulaud, D., Auclair, C., & Mouscadet, J. F. (2000) · Biochemistry · doi:10.1021/bi000398b · Cited by 131
Self-citationNew Class of HIV Integrase Inhibitors that Block Viral Replication in Cell Culture
Pannecouque, C. C., Pluymers, W., Maele, B. V., Tetz, V., Cherepanov, P., Clercq, E. D., Witvrouw, M., & Debyser, Z. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00952-1 · Cited by 100
King, P. J., & Robinson, W. E. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8420-8424.1998 · Cited by 91
Gerton, J. L., Ohgi, S., Olsen, M. N., DeRisi, J. L., & Brown, P. O. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5046-5055.1998 · Cited by 91
Johnson, A. A., Santos, W. L., Pais, G. C. G., Marchand, C., Amin, R., Burke, T. R., Verdine, G. L., & Pommier, Y. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511348200 · Cited by 86
Fikkert, V., Hombrouck, A., Remoortel, B. V., Maeyer, M. D., Pannecouque, C. C., Clercq, E. D., Debyser, Z., & Witvrouw, M. (2004) · AIDS · doi:10.1097/00002030-200410210-00006 · Cited by 84
Bonnenfant, S., Thomas, C. M., Vita, C., Subra, F., Deprez, E., Zouhiri, F., Desmaële, D., d’Angelo, J., Mouscadet, J. F., & Leh, H. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5728-5736.2004 · Cited by 82
Self-citationSinha, S., Pursley, M. H., & Grandgenett, D. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.7.3105-3113.2002 · Cited by 78
HIV integrase inhibitors as therapeutic agents in AIDS
Nair, V., & Chi, G. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.539 · Cited by 72
Cannon, P. M., Byles, E. D., Kingsman, S. M., & Kingsman, A. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.651-657.1996 · Cited by 66
The Hunt for HIV-1 Integrase Inhibitors
Lataillade, M., & Kozal, M. J. (2006) · AIDS Patient Care and STDs · doi:10.1089/apc.2006.20.489 · Cited by 55
Katzman, M., & Sudol, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1744-1753.1998 · Cited by 41
King, P. J., Lee, D. J., Reinke, R., Victoria, J. G., Beale, K. K., & Robinson, W. E. (2003) · Virology · doi:10.1016/s0042-6822(02)00042-9 · Cited by 37
Potential Drug Resistance Polymorphisms in the Integrase Gene of HIV Type 1 Subtype A
Herring, B. L., Cunningham, A. L., & Dwyer, D. E. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2004.20.1010 · Cited by 11
Cited by
Christ, F., Voet, A., Marchand, A., Nicolet, S., Desimmie, B. A., Marchand, D., Bardiot, D., Van der Veken, N. J., Van Remoortel, B., Strelkov, S. V., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.370 · Cited by 479
2015 update of the drug resistance mutations in HIV-1
Wensing, A. M. J., Cálvez, V., Ceccherini‐Silberstein, F., Charpentier, C., Günthard, H. F., Jacobsen, D. M., Paredes, R., Shafer, R. W., & Richman, D. D. (2015) · PubMed · doi:10.5167/uzh-122257 · Cited by 415
Tsiang, M., Jones, G. S., Goldsmith, J., Mulato, A., Hansen, D., Kan, E., Tsai, L., Bam, R. A., Stepan, G., Stray, K. M., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01474-16 · Cited by 290
Hare, S., Smith, S. J., Métifiot, M., Jaxa-Chamiec, A., Pommier, Y., Hughes, S. H., & Cherepanov, P. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073189 · Cited by 264
New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action
Tsiang, M., Jones, G. S., Niedziela-Majka, A., Kan, E., Lansdon, E. B., Huang, W., Hung, M., Samuel, D., Novikov, N., Xu, Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347534 · Cited by 167
Metadata
- Authors
- Malet, I., Delelis, O., Valantin, M.-A., Montes, B., Soulie, C., Wirden, M., Tchertanov, L., Peytavin, G., Reynes, J., Mouscadet, J.-F., Katlama, C., Calvez, V., & Marcelin, A.-G.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-04
- Volume
- 52
- Issue
- 4
- Pages
- 1351-1358
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2137646827
- Cited by
- 283
- References
- 37
- FWCI
- 27.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.